503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1873.85%
Net income growth above 1.5x BB's 159.47%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-50.00%
Negative yoy D&A while BB is 6.21%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
52.79%
Some yoy growth while BB is negative at -177.36%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-4.82%
Both reduce yoy usage, with BB at -310.75%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.82%
Negative yoy usage while BB is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-51.20%
Both negative yoy, with BB at -100.04%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-5.31%
Both yoy CFO lines are negative, with BB at -117.37%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
53.42%
CapEx growth well above BB's 25.66%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
2.20%
Some yoy expansion while BB is negative at -89.37%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-12.73%
We reduce yoy sales while BB is 2468.93%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-61.42%
We reduce yoy invests while BB stands at 70.10%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-25.52%
Both yoy lines negative, with BB at -98.51%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
52.95%
Buyback growth of 52.95% while BB is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.